DAFNA Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $932K | Sell |
|
|||||
|
2023
Q2 | $2.67M | Buy |
|
|||||
|
2023
Q1 | $2.1M | Buy |
|
|||||
|
2022
Q4 | $2.42M | Buy |
|
|||||
|
2022
Q3 | $2.55M | Sell |
|
|||||
|
2022
Q2 | $1.88M | Buy |
|
|||||
|
2022
Q1 | $1.41M | Buy |
|
|||||
|
2021
Q4 | $872K | Hold |
|
|||||
|
2021
Q3 | $1.32M | Buy |
|
|||||
|
2021
Q2 | $1.74M | Buy |
|
|||||
|
2021
Q1 | $2.01M | Buy |
|
|||||
|
2020
Q4 | $1.31M | Sell |
|
|||||
|
2020
Q3 | $2.84M | Sell |
|
|||||
|
2020
Q2 | $6.32M | Sell |
|
|||||
|
2020
Q1 | $2.34M | Buy |
|
|||||
|
2019
Q4 | $621K | Sell |
|
|||||
|
2019
Q3 | $793K | Buy |
|
|||||
|
2019
Q2 | $1.11M | Sell |
|
|||||
|
2019
Q1 | $2.12M | Buy |
|